![The prostate health index and the percentage of [-2]proPSA maintain their diagnostic performance when calculated with total and free PSA from different manufacturers](https://www.degruyter.com/document/doi/10.1515/cclm-2021-0554/asset/graphic/j_cclm-2021-0554_fig_001.jpg "The prostate health index and the percentage of [-2]proPSA maintain their diagnostic performance when calculated with total and free PSA from different manufacturers")
The prostate health index and the percentage of [-2]proPSA maintain their diagnostic performance when calculated with total and free PSA from different manufacturers
Quadriptyque PRO-PSA - DS12 (FEB 2014) UK_394x210
![Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis](https://www.degruyter.com/document/doi/10.1515/cclm-2012-0410/asset/graphic/j_cclm-2012-0410_fig_003.jpg "Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis")
Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis
![Accuracy of [-2]proPSA for detecting aggressive prostate cancer at... | Download Scientific Diagram](https://www.researchgate.net/publication/350199445/figure/tbl1/AS:1043362580791297@1625768432519/Accuracy-of-2proPSA-for-detecting-aggressive-prostate-cancer-at-different-threshold.png "Accuracy of [-2]proPSA for detecting aggressive prostate cancer at... | Download Scientific Diagram")
Accuracy of [-2]proPSA for detecting aggressive prostate cancer at... | Download Scientific Diagram
PHI in the Early Detection of Prostate Cancer | Anticancer Research
![−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-016-0131-0/MediaObjects/12894_2016_131_Fig2_HTML.gif "−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text")
−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report | BMC Urology | Full Text
NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 5S (2018)
Current biomarkers for diagnosing of prostate cancer | Future Oncology
![Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature – topic of research paper in Clinical medicine.](https://cyberleninka.org/viewer_images/859140/f/1.png "Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature – topic of research paper in Clinical medicine.")
Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature – topic of research paper in Clinical medicine.
pn_314_1.png
![2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fpcan.2013.50/MediaObjects/41391_2014_Article_BFpcan201350_Fig1_HTML.jpg "2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases")
2]proPSA is an early marker for prostate cancer aggressiveness | Prostate Cancer and Prostatic Diseases
![The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis](https://www.degruyter.com/document/doi/10.1515/labmed-2016-0056/asset/graphic/j_labmed-2016-0056_fig_001.jpg "The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis")
The performance of [-2]proPSA and prostate health index tumor markers in prostate cancer diagnosis
![2]proPSA e Prostate Health Index (phi): che cosa sono? quando sono utili? - Dr. Francesco Varvello, urologo e andrologo](https://image.jimcdn.com/app/cms/image/transf/none/path/s21d176b569682d9d/image/icb5469c22bc7d9a6/version/1605475842/image.png "2]proPSA e Prostate Health Index (phi): che cosa sono? quando sono utili? - Dr. Francesco Varvello, urologo e andrologo")
2]proPSA e Prostate Health Index (phi): che cosa sono? quando sono utili? - Dr. Francesco Varvello, urologo e andrologo
![a, b uPSA and [−2]proPSA mean observed values at 1-3-6-9-12 months... | Download Scientific Diagram](https://www.researchgate.net/profile/Roberto-Scarpa-2/publication/299423342/figure/fig2/AS:667671179829279@1536196622971/a-b-uPSA-and-2proPSA-mean-observed-values-at-1-3-6-9-12-months-after-radical_Q640.jpg "a, b uPSA and [−2]proPSA mean observed values at 1-3-6-9-12 months... | Download Scientific Diagram")
a, b uPSA and [−2]proPSA mean observed values at 1-3-6-9-12 months... | Download Scientific Diagram
PHI in the Early Detection of Prostate Cancer
KoreaMed Synapse
![Mixed linear models for uPSA and [−2]proPSA repeated measures | Download Table](https://www.researchgate.net/publication/299423342/figure/tbl2/AS:667671184015360@1536196623057/Mixed-linear-models-for-uPSA-and-2proPSA-repeated-measures.png "Mixed linear models for uPSA and [−2]proPSA repeated measures | Download Table")
Mixed linear models for uPSA and [−2]proPSA repeated measures | Download Table
